Lume Meso Phase III Results
Results of LUME-Meso trial in malignant pleural mesothelioma presented at the 19th World Conference on Lung Cancer (WCLC 2018)The primary endpoint of progression-free survival was not met in the Phase III LUME-Meso Trial
Source: Boehringer Ingelheim Corporate News - Category: Research Source Type: news
More News: Asbestosis | Cancer | Cancer & Oncology | Conferences | Lung Cancer | Mesothelioma | Research